PlainRecalls
FDA Devices Moderate Class II Ongoing

CoViPoint COVID test kit (MultiPLEX/Direct) Kit Item Numbers: BC-DK0200; BM-AD4K0200 BM-ADK0200 BM-CDK0200 BM-CFDK0200 BM-D4K0200 BM-DK0200 BM-DK0600 BM-DK0800 BM-DK1200 BM-DK1400 BM-DK1800

Reported: December 7, 2022 Initiated: August 8, 2022 #Z-0324-2023

Product Description

CoViPoint COVID test kit (MultiPLEX/Direct) Kit Item Numbers: BC-DK0200; BM-AD4K0200 BM-ADK0200 BM-CDK0200 BM-CFDK0200 BM-D4K0200 BM-DK0200 BM-DK0600 BM-DK0800 BM-DK1200 BM-DK1400 BM-DK1800

Reason for Recall

Distribution of COVID Test Kits without FDA Approval, Clearance or Authorization.

Details

Recalling Firm
GS Biomark LLC
Units Affected
639,200 kits
Distribution
U.S.: TX, NY, GA, IN, MD, CA, PA, MD, DC, NJ, OR, WA O.U.S.: None
Location
Bellevue, WA

Frequently Asked Questions

What product was recalled?
CoViPoint COVID test kit (MultiPLEX/Direct) Kit Item Numbers: BC-DK0200; BM-AD4K0200 BM-ADK0200 BM-CDK0200 BM-CFDK0200 BM-D4K0200 BM-DK0200 BM-DK0600 BM-DK0800 BM-DK1200 BM-DK1400 BM-DK1800. Recalled by GS Biomark LLC. Units affected: 639,200 kits.
Why was this product recalled?
Distribution of COVID Test Kits without FDA Approval, Clearance or Authorization.
Which agency issued this recall?
This recall was issued by the FDA Devices on December 7, 2022. Severity: Moderate. Recall number: Z-0324-2023.